Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
4.83
-0.11 (-2.23%)
At close: Jun 17, 2025, 3:02 PM
Y-mAbs Therapeutics Revenue
Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending March 31, 2025, Y-mAbs Therapeutics generated $20.9M in revenue.
Revenue (ttm)
$87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
$843.13K
Employees
104
Market Cap
218.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|